Vanguard Group Inc 10x Genomics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,101,536 shares of TXG stock, worth $204 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,101,536
Previous 9,011,332
1.0%
Holding current value
$204 Million
Previous $504 Million
32.26%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding TXG
# of Institutions
308Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Baillie Gifford & CO7.42MShares$166 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$141 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$135 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$116 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.66MShares$82 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.13B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...